These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 856917)

  • 1. Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans.
    Ogra PL; Chow T; Beutner KR; Rubi E; Strussenberg J; DeMello S; Rizzone C
    J Infect Dis; 1977 Apr; 135(4):499-506. PubMed ID: 856917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a neuraminidase-specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection.
    Beutner KR; Chow T; Rubi E; Strussenberg J; Clement J; Ogra PL
    J Infect Dis; 1979 Dec; 140(6):844-50. PubMed ID: 396336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immune responses to the hemagglutinin and neuraminidase antigens of influenza A virus after immunization in humans.
    Chow TC; Beutner KR; Ogra PL
    Infect Immun; 1979 Jul; 25(1):103-9. PubMed ID: 478632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR; Rizzone C; DeMello S; Ogra PL
    Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine.
    Potter CW; Jennings R; Phair JP; Clarke A; Stuart-Harris CH
    J Infect Dis; 1977 Mar; 135(3):423-31. PubMed ID: 850080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
    Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
    J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live Victoria/75-ts-1[E] influenza A virus vaccines in adult volunteers: role of hemagglutinin immunity in protection against illness and infection caused by influenza A virus.
    Douglas RG; Markoff LJ; Murphy BR; Chanock RM; Betts RF; Hayden FG; Levine MM; Van Blerk GA; Sotman SB; Nalin DR
    Infect Immun; 1979 Oct; 26(1):274-9. PubMed ID: 500204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the protective efficacies of the live vaccine RIT 4025 and an inactivated vaccine against a natural heterologous A/Victoria/3/75 infection.
    Delem A; Van Rensburg W; Flaskett I
    J Hyg (Lond); 1979 Oct; 83(2):221-9. PubMed ID: 385764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemagglutinin and neuraminidase specific cell-mediated immune responses to influenza A virus following immunization in guinea pigs.
    Chow TC; Beutner KR; Ogra PL
    Immunol Commun; 1980; 9(1):33-53. PubMed ID: 6154010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus.
    Clements ML; Betts RF; Tierney EL; Murphy BR
    J Clin Microbiol; 1986 Jul; 24(1):157-60. PubMed ID: 3722363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live, attenuated influenza A/England/42/72 (H3N2) virus vaccine: a field trial.
    Rubin RJ; Noble GR; Corey L; Brown WJ; Brandling-Bennett D; Kaye HS; Coleman MT; Gregg MB; Dowdle WR
    J Infect Dis; 1976 Jun; 133(6):613-20. PubMed ID: 778302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection.
    Oxford JS; Schild GC; Potter CW; Jennings R
    J Hyg (Lond); 1979 Feb; 82(1):51-61. PubMed ID: 105040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
    Muhamed G; Greenbaum E; Zakay-Rones Z
    Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans.
    Kilbourne ED
    J Infect Dis; 1976 Oct; 134(4):384-94. PubMed ID: 789791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines].
    Naĭkhin AN; Tsaritsyna IM; Syrodoeva LG; Oleĭnikova EV; Gorev NE
    Vopr Virusol; 1983; (2):154-9. PubMed ID: 6868553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children.
    Gross PA; Ennis FA; Gaerlan PF; Denson LJ; Denning CR; Schiffman D
    J Infect Dis; 1977 Nov; 136(5):623-32. PubMed ID: 335000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials with a new influenza subunit vaccine in adults and children.
    Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz AJ
    Dev Biol Stand; 1977 Jun 1-3; 39():297-302. PubMed ID: 342311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans.
    Kilbourne ED; Couch RB; Kasel JA; Keitel WA; Cate TR; Quarles JH; Grajower B; Pokorny BA; Johansson BE
    Vaccine; 1995 Dec; 13(18):1799-803. PubMed ID: 8701596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain-specificity of antibody to haemagglutinin following inactivated A/port chalmers/1/73 vaccine in man: evidence for a paradoxical strain-specific antibody response.
    Schild GC; Smith JW; Cretescu L; Newman RW; Wood JM
    Dev Biol Stand; 1977 Jun 1-3; 39():273-81. PubMed ID: 604109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.